BXP — Beximco Pharmaceuticals Share News
0.000.00%
Last trade - 00:00- £240.90m
- £253.42m
- BDT49.12bn
Beximco Pharmaceut - Update on the supply of COVID-19 vaccine
Brief: Beximco Pharmaceuticals In Early Stage Of Establishing In-House Vaccine Capability
Beximco Pharmaceut - Statement re: media comment
Beximco Pharmaceut - Notice of AGM
India's Dr. Reddy's open to making Pfizer COVID pill after Merck deal
Beximco Pharmaceut - Results for First Quarter Ended 30 September 2021
Brief: Beximco's generic molnupiravir for COVID-19 to cost 70 taka per capsule
Beximco to sell generic version of Merck COVID-19 pill, London shares rise
Bangladesh's Beximco to sell generic version of Merck COVID-19 pill (updated)
Asian firm Beximco to sell generic version of Merck COVID-19 pill
Beximco Pharmaceut - Launch of world’s first generic molnupiravir
Beximco Pharmaceut - Results for the year ended 30 June 2021
Beximco Pharmaceut - Notification of Preliminary Results and AGM
Brief: Beximco Pharmaceuticals Updates On Supply Of Covid-19 Vaccine
Beximco Pharmaceut - Update on the supply of COVID-19 vaccine
Beximco Pharmaceut - Completion of Sanofi Bangladesh Acquisition
Beximco Pharmaceut - Sanofi Bangladesh Share Purchase Agreement signed
Beximco Pharmaceut - Acquisition Approved by Bangladesh Bank
Beximco Pharmaceut - Statement re: media comment